Why is the A2 Milk share price underperforming on Tuesday?

A broker downgrade is weighing on this infant formula company's shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market may be charging higher today, but the A2 Milk Company Ltd (ASX: A2M) share price hasn't been able to follow its lead.

In afternoon trade, the infant formula company's shares are down 1.5% to $5.87.

A young man stands facing the camera and scratching his head with the other hand held upwards wondering if he should buy Whitehaven Coal shares

Image source: Getty Images

Why is the A2 Milk share price underperforming?

The weakness in the A2 Milk share price on Tuesday has been driven by the release of a broker note out of Bell Potter this morning.

According to the note, the broker has downgraded the company's shares to a hold rating with a reduced price target of $6.80.

While this still implies decent upside from current levels, the broker doesn't appear to believe the risk/reward is compelling enough to retain its buy rating.

What did the broker say?

Bell Potter has been analysing the results and commentary from A2 Milk's dairy processing partner Synlait Milk (ASX: SM1) and seems a touch concerned with what it saw.

The broker believes that A2 Milk could now be destined to fall short of consensus estimates in the near term. It explained:

The recent SM1 downgrade was reflective of changes to existing IMF customer orders, elevated cost structures (some of which is recoverable in customer agreements) and a delayed ramp-up of the new Pokeno nutritionals customer. What the SM1 result highlighted to us, was that our nutritionals forecasts for SM1 (and hence A2M IMF demand) have been softer than consensus expectations and this is also reflected in our below consensus FY24e A2M forecasts

We downgrade from Buy to Hold. Ultimately A2M and SM1 balance dates don't align and SM1 issues may simply reflect restocking and destocking decisions on the part of A2M around SAMR registration. While we like the long-term story in A2M, we are cognisant that FY24e market expectations are higher than ours and unfortunately we saw more in the recent SM1 1H23 result to support our current forecasts than make us consider materially upgrading them.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Should you buy Coles, Light & Wonder, and TPG Telecom shares in April?

Let's see if the team at Morgans rates these shares as buys ahead of the new month.

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares

Let’s see if they are bullish or bearish on these names.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Miner and company person analysing results of a mining company.
Broker Notes

3 reasons to buy BHP shares today

Two leading investment analysts offer their outlook for the BHP share price.

Read more »